Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.

Documenti analoghi

• Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.
  di: Martin, J M, et al.
  Pubblicazione: (1988)
• Vasoactive intestinal peptide (VIP).
  di: Bryant, M G
  Pubblicazione: (1978)
• The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor.
  di: Couvineau, A, et al.
  Pubblicazione: (1985)
• The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature.
  di: el Battari, A, et al.
  Pubblicazione: (1987)
• Hormonal control of fructose 2,6-bisphosphate concentration in the HT29 human colon adenocarcinoma cell line. Alpha 2-adrenergic agonists counteract effect of vasoactive intestinal peptide.
  di: Denis, C, et al.
  Pubblicazione: (1986)